FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3123226110> ?p ?o ?g. }

• W3123226110 startingPage "34" @default.
• W3123226110 abstract "This article examines the implications of U.S. federal and international regulatory mandates in the construction and circulation of racial categories in biomedical research and drug development. It will focus on the interface between two regulatory mandates in particular: the International Conference on Harmonization (ICH) Guideline Document E-5 on Ethnic Factors in the Acceptability of Foreign Clinical Data, and the U.S. Food and Drug Administration (FDA) Guidance for Industry: Collection of Race and Ethnicity Data in Clinical Trials. The ostensible purpose of both of these guidelines is to promote more efficient and economical development of new pharmaceutical interventions. Underlying both Guidances is a presumption that race and ethnicity are relevant variables in assessing the safety and efficacy of drugs in clinical trials. Both Guidances also implicitly cast race and ethnicity as obstacles to be managed and overcome in the course of getting new drugs to global markets as quickly and cheaply as possible. The ICH process is transforming global drug development and marketing, and, in particular, is opening up the large Japanese market to pharmaceuticals tested in the West. The FDA Guidance similarly promises to transform the production and organization of racial and ethnic data in clinical trials for the U.S. market. As pharmaceutical development goes global, however, the social classifications of the FDA Guidance also promise to collide with the mixture of social, physiological and genetic factors elaborated in the ICH guideline. These diverse classificatory schemes cannot be easily reconciled. This paper will explore how concepts of race and ethnicity are being produced and reproduced through this collision. It will further explore how these distinct attempts to regulate race in a bureaucratic context are shaping the development of global pharmaceutical markets. Part II of the article will set forth the background to the ICH E5 regulatory mandate and its distinct concepts of race and ethnicity. Part III will explore how the ICH guidelines have already begun to affect global pharmaceutical development. Part IV will set forth the background to the FDA guidelines on the collection of racial and ethnic data for clinical trials. It will then go on to examine the debates that arose around the adoption of the FDA guidelines, specifically as they involved considerations of how the FDA guidelines might impact global pharmaceutical development under the ICH regulatory regime. Part V will conclude the article with an examination of the broader implications of this story for the production of social and regulatory understandings of the nature of race and ethnicity." @default.
• W3123226110 created "2021-02-01" @default.
• W3123226110 creator A5017994198 @default.
• W3123226110 date "2006-01-01" @default.
• W3123226110 modified "2023-09-25" @default.
• W3123226110 title "Harmonizing Race: Competing Regulatory Paradigms of Racial Categorization in International Drug Development" @default.
• W3123226110 hasPublicationYear "2006" @default.
• W3123226110 type Work @default.
• W3123226110 sameAs 3123226110 @default.
• W3123226110 citedByCount "1" @default.
• W3123226110 countsByYear W31232261102016 @default.
• W3123226110 crossrefType "journal-article" @default.
• W3123226110 hasAuthorship W3123226110A5017994198 @default.
• W3123226110 hasConcept C107993555 @default.
• W3123226110 hasConcept C118552586 @default.
• W3123226110 hasConcept C121332964 @default.
• W3123226110 hasConcept C137403100 @default.
• W3123226110 hasConcept C142724271 @default.
• W3123226110 hasConcept C144024400 @default.
• W3123226110 hasConcept C144133560 @default.
• W3123226110 hasConcept C17744445 @default.
• W3123226110 hasConcept C199539241 @default.
• W3123226110 hasConcept C24890656 @default.
• W3123226110 hasConcept C27415008 @default.
• W3123226110 hasConcept C2779962950 @default.
• W3123226110 hasConcept C2780035454 @default.
• W3123226110 hasConcept C2780182762 @default.
• W3123226110 hasConcept C2780253743 @default.
• W3123226110 hasConcept C3018890749 @default.
• W3123226110 hasConcept C39549134 @default.
• W3123226110 hasConcept C535046627 @default.
• W3123226110 hasConcept C64903051 @default.
• W3123226110 hasConcept C71924100 @default.
• W3123226110 hasConcept C76509639 @default.
• W3123226110 hasConcept C98274493 @default.
• W3123226110 hasConceptScore W3123226110C107993555 @default.
• W3123226110 hasConceptScore W3123226110C118552586 @default.
• W3123226110 hasConceptScore W3123226110C121332964 @default.
• W3123226110 hasConceptScore W3123226110C137403100 @default.
• W3123226110 hasConceptScore W3123226110C142724271 @default.
• W3123226110 hasConceptScore W3123226110C144024400 @default.
• W3123226110 hasConceptScore W3123226110C144133560 @default.
• W3123226110 hasConceptScore W3123226110C17744445 @default.
• W3123226110 hasConceptScore W3123226110C199539241 @default.
• W3123226110 hasConceptScore W3123226110C24890656 @default.
• W3123226110 hasConceptScore W3123226110C27415008 @default.
• W3123226110 hasConceptScore W3123226110C2779962950 @default.
• W3123226110 hasConceptScore W3123226110C2780035454 @default.
• W3123226110 hasConceptScore W3123226110C2780182762 @default.
• W3123226110 hasConceptScore W3123226110C2780253743 @default.
• W3123226110 hasConceptScore W3123226110C3018890749 @default.
• W3123226110 hasConceptScore W3123226110C39549134 @default.
• W3123226110 hasConceptScore W3123226110C535046627 @default.
• W3123226110 hasConceptScore W3123226110C64903051 @default.
• W3123226110 hasConceptScore W3123226110C71924100 @default.
• W3123226110 hasConceptScore W3123226110C76509639 @default.
• W3123226110 hasConceptScore W3123226110C98274493 @default.
• W3123226110 hasIssue "1" @default.
• W3123226110 hasLocation W31232261101 @default.
• W3123226110 hasOpenAccess W3123226110 @default.
• W3123226110 hasPrimaryLocation W31232261101 @default.
• W3123226110 hasRelatedWork W1427274180 @default.
• W3123226110 hasRelatedWork W1533897093 @default.
• W3123226110 hasRelatedWork W1995892870 @default.
• W3123226110 hasRelatedWork W2008918244 @default.
• W3123226110 hasRelatedWork W2012292757 @default.
• W3123226110 hasRelatedWork W2039427726 @default.
• W3123226110 hasRelatedWork W2110058244 @default.
• W3123226110 hasRelatedWork W2126339875 @default.
• W3123226110 hasRelatedWork W2225025942 @default.
• W3123226110 hasRelatedWork W2345640151 @default.
• W3123226110 hasRelatedWork W248843039 @default.
• W3123226110 hasRelatedWork W2550177206 @default.
• W3123226110 hasRelatedWork W2609179529 @default.
• W3123226110 hasRelatedWork W2808220865 @default.
• W3123226110 hasRelatedWork W2899623366 @default.
• W3123226110 hasRelatedWork W2980888304 @default.
• W3123226110 hasRelatedWork W3191977759 @default.
• W3123226110 hasRelatedWork W2062247085 @default.
• W3123226110 hasRelatedWork W2185302052 @default.
• W3123226110 hasRelatedWork W2187521430 @default.
• W3123226110 hasVolume "5" @default.
• W3123226110 isParatext "false" @default.
• W3123226110 isRetracted "false" @default.
• W3123226110 magId "3123226110" @default.
• W3123226110 workType "article" @default.